PANIBRATIUK, O. A.; Yakovleva O. А. ASSESSMENT OF BLEEDING RISK FACTORS DURING WARFARIN THERAPY IN ISCHEMIC HEART DISEASE COMPLICATED BY ATRIAL FIBRILLATION. Medical and Clinical Chemistry, [S. l.], n. 2, p. 24–32, 2022. DOI: 10.11603/mcch.2410-681X.2022.i2.13202. Disponível em: https://ojs.tdmu.edu.ua/index.php/MCC/article/view/13202. Acesso em: 3 jul. 2024.